Elysium Health was created in 2014 by Dr. Leonard Guarente, Eric Marcotulli, and Dan Alminana. Dr. Guarente is the director of the Glenn Center for Biology of Aging Research at MIT, while Marcotulli and Alminana are businessmen coming from venture capital and investment banking respectively.
Since its founding, Elysium Health has been working to help people live healthier, longer. The company seeks to translate advances in science and technology into clinically validated products that work.
Elysium Health partners with world-class scientists that work at universities like Oxford, Cambridge, and Harvard. These scientists help steer the company’s direction and its research.
Basis is the first product created by Elysium Health. It has been on sale since 2015. It is currently the only product Elysium Health sells, but the company is in the process of new products. These products are currently in various stages of pre-clinical and clinical trials.
Basis works to support cellular health by increasing levels of NAD+ in cells. This coenzyme decreases in levels as we age. Scientists believe that NAD+ is responsible for helping hundreds of vital cellular functions like DNA protection and circadian rhythms, which is why Basis works to ensure that levels of NAD+ stay high as we age.
A clinical trial for Basis took place in 2016. 120 participants were divided into three equal groups with one group taking the recommended daily dose of Basis, another group taking a double dose of the supplement, and the third group taking a placebo. The trial’s results showed that Basis increased levels of NAD+ by an average of 40 percent.
Basis is available for purchase on Elysium Health’s website. An individual jar contains about a month’s worth of the supplement and costs $60. Monthly subscriptions to Basis are available for $40 to $50 per month depending on the length of the subscription.
For more information about the science behind Basis, the Elysium Health itself, or the scientists collaborating with the company visit Elysium’s website.